Assessing Blood Flow in Lung Tumors with Technetium-99m HMPAO and SPECT
Author Information
Author(s): N.P. Rowell, V.R. McCready, D. Tait, M.A. Flower, B. Cronin, G.E. Adams, A. Horwich
Primary Institution: Royal Marsden Hospital
Hypothesis
Can technetium-99m HMPAO and SPECT effectively assess blood flow patterns in human lung tumors?
Conclusion
The study found that technetium-99m HMPAO with SPECT is an effective and reproducible technique for demonstrating patterns of blood flow in lung tumors.
Supporting Evidence
- Blood flow patterns were assessed in 20 patients using technetium-99m HMPAO.
- Uptake ratios ranged from 0.35 to 1.53, indicating variability in blood flow.
- Thirteen tumors showed lower uptake in central regions compared to the whole tumor.
- Reproducibility of the technique was confirmed with duplicate scans in eight patients.
Takeaway
Doctors used a special dye to see how blood flows in lung tumors, helping them understand how to treat them better.
Methodology
Twenty patients received technetium-99m HMPAO before undergoing SPECT to measure blood flow in their lung tumors.
Limitations
Some tumors could not be evaluated due to large pleural effusions or indistinguishable tumors from surrounding lung.
Participant Demographics
17 male and 3 female patients, median age 70.5 years, with various types of lung tumors.
Statistical Information
P-Value
0.002
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website